Accepted Manuscript
Spontaneous ultra-weak photon emission in correlation to
inflammatory metabolism and oxidative stress in a mouse model
of collagen-induced arthritis
Min He, Eduard van Wijk, Herman van Wietmarschen, Mei
Wang, Mengmeng Sun, Slavik Koval, Roeland van Wijk, Thomas
Hankemeier, Jan van der Greef
PII:
DOI:
Reference:
S1011-1344(16)30753-9
doi: 10.1016/j.jphotobiol.2016.12.036
JPB 10725
To appear in:
Journal of Photochemistry & Photobiology, B: Biology
Received date:
Revised date:
Accepted date:
2 September 2016
22 December 2016
23 December 2016
Please cite this article as: Min He, Eduard van Wijk, Herman van Wietmarschen, Mei
Wang, Mengmeng Sun, Slavik Koval, Roeland van Wijk, Thomas Hankemeier, Jan van
der Greef , Spontaneous ultra-weak photon emission in correlation to inflammatory
metabolism and oxidative stress in a mouse model of collagen-induced arthritis. The
address for the corresponding author was captured as affiliation for all authors. Please
check if appropriate. Jpb(2017), doi: 10.1016/j.jphotobiol.2016.12.036
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
ACCEPTED MANUSCRIPT
Spontaneous ultra-weak photon emission in
correlation to inflammatory metabolism and
oxidative stress in a mouse model of collageninduced arthritis
Min He1,2, Eduard van Wijk1,2,5,6*, Herman van Wietmarschen1,2,4, Mei Wang1,2,3,6,
CR
IP
T
Mengmeng Sun1,2,6, Slavik Koval1, Roeland van Wijk2,5, Thomas Hankemeier1,2 and Jan
van der Greef1,2,4
1
Analytical BioSciences, LACDR, Leiden University, P.O. Box 9502, 2300 RA, Leiden, the Netherlands
2
Sino-Dutch Center for Preventive and Personalized Medicine, Leiden University, P.O. Box 9502, 2300 RA, Leiden,
US
the Netherlands
SU Biomedicine, Utrechtseweg 48, 3700 AJ, Zeist, the Netherlands
4
TNO, P.O. Box 360, 3700 AJ, Zeist, the Netherlands
5
Meluna Research, Geldermalsen, the Netherlands
6
Changchun University of Chinese Medicine, No. 1035, Boshuo Rd, Jingyue Economic Development District,
M
Changchun 130117, China
AN
3
* Corresponding author:
[email protected] (Eduard van Wijk)
AC
CE
PT
ED
Abstract: The increasing prevalence of rheumatoid arthritis has driven the development of
new approaches and technologies for investigating the pathophysiology of this devastating,
chronic disease. From the perspective of systems biology, combining comprehensive personal
data such as metabolomics profiling with ultra-weak photon emission (UPE) data may provide
key information regarding the complex pathophysiology underlying rheumatoid arthritis. In
this article, we integrated UPE with metabolomics-based technologies in order to investigate
collagen-induced arthritis, a mouse model of rheumatoid arthritis, at the systems level, and we
investigated the biological underpinnings of the complex dataset. Using correlation networks,
we found that elevated inflammatory and ROS-mediated plasma metabolites are strongly
correlated with a systematic reduction in amine metabolites, which is linked to muscle wasting
in rheumatoid arthritis. We also found that increased UPE intensity is strongly linked to
metabolic processes (with correlation co-efficiency |r| value >0.7), which may be associated
with lipid oxidation that related to inflammatory and/or ROS-mediated processes. Together,
these results indicate that UPE is correlated with metabolomics and may serve as a valuable
tool for diagnosing chronic disease by integrating inflammatory signals at the systems level.
Our correlation network analysis provides important and valuable information regarding the
disease process from a system-wide perspective.
Key words: Collagen-induced arthritis, correlation networks, systems biology, metabolomics,
ultra-weak photon emission
1
ACCEPTED MANUSCRIPT
1. Introduction
AC
CE
PT
ED
M
AN
US
CR
IP
T
Rheumatoid arthritis (RA) is one of the most prevalent chronic auto-immune diseases,
occurring in about approximately 1% of the population in Western countries [1], [2]. RA
manifests as a complex inflammatory syndrome that typically includes joint swelling, pain,
and hyperthermia, as well as synovial hyperplasia and destruction of cartilage and bones in
the joints. RA is considered a systemic disease that is caused by a variety of
pathophysiological processes [3]. These processes are accompanied by increased levels of
cytokines such as tumor necrosis factor α (TNF-α) and interleukins (IL-1β and IL-6) in the
blood and interstitial fluids, activation of NF-κB pathways (to inhibit apoptosis in various
immune cells), and systemic disruptions in inflammatory metabolite synthesis [4]–[6].
Experimental studies of RA—particularly the pathophysiological mechanisms of
therapeutic interventions—are often conducted using animal models. The most commonly
used model for RA is the collagen-induced arthritis (CIA) mouse model, which has
pathophysiological processes and features similar to patients with RA [7]–[11]. In addition,
advances in metabolomics technology, which now enable researchers to measure extremely
low concentrations of metabolites in several pathways simultaneously [12], has facilitated the
study of RA in considerably more detail, thereby increasing our understanding of the
pathological mechanisms that underlie the disease [13]. We previously studied the
differences in molecular profiles between CIA mice and control mice by examining
differences with respect to inflammation and reactive oxygen species (ROS), analyzed using
univariate and multivariate metrics [14]. In addition to the well-characterized inflammatory
phenomenon, issues related to muscle wasting and energy expenditure are also present in RA
[15]–[18], and this is reflected by the presence of amine metabolites in the plasma of CIA
mice [19].
Differences between CIA mice and control mice were also observed with respect to the
intensity of ultra-weak photon emission (UPE), which reflects differences in the organization
of the system at a biophysical level [20]. UPE is a process that occurs in all living organisms
and is the spontaneous emission of light with extremely weak intensity (101–103
photons/sec/cm2) in the UV, visible, and near-IR spectra [21]. Many studies have focused on
the relationship between UPE and ROS production during metabolic processes [22]–[26].
Considering that ROS production is closely associated with inflammatory diseases and
impaired metabolic processes, it is reasonable to expect that UPE is also associated with
inflammatory disease and/or metabolic processes. UPE might therefore be used to help
diagnose inflammation and inflammation-related diseases. UPE has been proposed for
monitoring lipid peroxidation in cell membranes [27], and applications using UPE in human
studies—and their potential relationship with ROS—were summarized by van Wijk [23].
Moreover, the putative relationship between UPE, physiological state, and metabolic
processes has been proposed by several research groups [28]–[31]. Here, we performed an
integrated analysis of the biochemical and biophysical differences between CIA mice and
control mice, based on the hypothesis that a combined analysis would reveal unique insight
into the biochemical and biophysical changes that occur during RA.
Network biology is an emerging field in biomedical research, and network biology tools
are increasingly used to identify clusters of correlated parameters, to visualize or explore
high-dimensional data, and to understand or interpret interactions that reflect part of a
complex biological system [32], [33]. Correlation networks have been used in “omics”
studies to combine complex data sets, for example combinations of metabolomics, genomics,
and/or proteomics data sets. Correlation networks are also used to support the biological
interpretation of large data profiles and to differentiate disease phenotypes [34]–[37]. Here,
we expanded the systems-based approach of correlation-based analyses in order to examine
the relationship between metabolomics profiling and UPE data. Using this correlation
network analysis, we visualized systematic perturbations in bio-photons, inflammatory
2
ACCEPTED MANUSCRIPT
processes, and ROS-related mediators. This approach may be used to facilitate the diagnosis
of disease and/or to discriminate between disease syndromes, particularly with respect to
complex chronic diseases such as RA and type 2 diabetes mellitus.
2. Materials and Methods
2.1 Animal study samples, Modelling, and ethics Statement
CR
IP
T
CIA was induced by the intraperitoneal injection of type II collagen and
lipopolysaccharide in adult (6-7 weeks of age) DBA/1J male mice as described previously
[38]; the CIA and control (Ctrl) groups contained 10 mice each. The injections were
performed on days 0, 14, 28, 42, and 56; UPE intensity was then measured in each paw (day
70th), and blood was collected into pre-cooled EDTA tubes (BD Vacutainer, Plymouth, UK)
immediately after UPE measurements. The blood samples were centrifuged at 3000×g for 10
minutes, and then stored at -80ºC until metabolic measurements were performed [14]. All
animal experiments were performed in compliance with the Guide for the Care and Use of
Laboratory Animals (National Institutes of Health, Bethesda, MD). All animal care and
experiments were approved by the Tohoku Institute of Technology Research Ethics
Committee, Sendai, Japan.
US
2.2 Instruments and data acquisition
CE
PT
ED
M
AN
2.2.1 UPE instruments and settings
UPE was measured using a 600 series CCD camera system (Spectral Instruments, Inc.,
Tucson, AZ) equipped with a closed-cycle mechanical cryogenic unit (held at -120°C) as the
cooling system. Prior to the UPE measurement, mice were maintained in controlled dark
conditions. The detailed settings of the CCD system including figures about the measured
location on mice is described in Van Wijk et al [20]. In brief, the CCD camera with 2048
×2048 pixel resolution and 13.5×13.5 mm pixel size was mounted on the top of a dark
chamber, and the animal was immobilized using isoflurane anesthesia. A specially designed
lens system with 0.5 numerical aperture (on the detector side) and 7 pieces of the restricted
number of lenses was used for the UPE measurement, leading 47 photon/s/cm2 as a minimum
detectable number of photons on each pixel. Using this equipment, UPE can be described by
intensity (counts/15 min/pixel ) at five independent regions on each paw , and was used for
further correlation analysis. The regions were named according to the paw measured, and
numbers were added (ranging from 1 to 5, indicating the location closest to the tip of the paw
through the location farthest from the tip of the paw) as follows: LFP (left front paw) 1
through LFP5; LHP (left hind paw) 1 through LHP5; RFP (right front paw) 1 through RFP5;
and RHP (right hind paw) 1 through RHP5.
AC
2.2.2 Extraction of plasma metabolites and metabolomics analysis
Plasma samples were aliquoted and extracted via different methods in order to obtain
separate classes of compounds, including oxylipins, amine metabolites, and oxidative stress‒
related metabolites. Oxylipins (bioactive lipid mediators derived from polyunsaturated fatty
acids) were extracted using solid phase extraction and analyzed using an Agilent 1290 HPLC
coupled to an Agilent 6490 triple quadrupole mass spectrometer with electrospray ionization
as described previously [14], [39]. Amine metabolites (including free amino acids and their
biogenic metabolites) were extracted using AccQ-TagAQC derivatization and analyzed using
a Waters ACQUITY UPLC coupled to a Waters Xevo mass spectrometer with electrospray
ionization source as described by Noga et al. [40]. Oxidative stress‒mediated metabolites—
primarily PGs/IsoPGs, NO2-FAs, lysophosphatidic acids, and sphingosine/sphingosinerelated sphingolipids—were extracted using liquid–liquid extraction and analyzed using a
validated method with an Agilent 1290 HPLC coupled to an Agilent 6490 triple quadrupole
mass spectrometer with electrospray ionization. The peak area of each target compound was
3
ACCEPTED MANUSCRIPT
corrected using the appropriate internal standard (ISTD), leading to a ratio (target
compound/ISTD) that was used for further analysis in the correlation study.
2.3 Data preprocessing and statistical analysis
CR
IP
T
The metabolomics and UPE data collected from both the CIA and Ctrl groups were included
in the correlation analysis. Univariate correlations were performed using the Spearman’s rank
correlation method using RStudio software (version 3.0.3). Absolute values of the
Spearman’s rank correlation coefficient (|r|) >0.7 were considered to reflect a strong
correlation between parameters, and this threshold was used to create highly correlated
graphical networks using Cytoscape software (version 3.3.0, http://www.cytoscape.org) with
the MetScape plug-in for extracting and integrating information and for visualizing the
correlation networks [41], [42]. Positive and negative correlations were indicated by positive
and negative values of r, respectively.
3. Results and Discussion
3.1 Collagen-induced arthritis alters the local distribution of UPE
AC
CE
PT
ED
M
AN
US
Differences in UPE between CIA and Ctrl mice have been reported previously [20]. A
schematic figure was displayed, in order to show the CCD setup of UPE instrument as well
as the locations for UPE measurements on mouse front and hind paws (Fig. 1). Here, we used
correlation networks to visualize the relationship between individual UPE intensities at the
locations measured in both CIA mice and in Ctrl mice (Fig. 2), as visualizing the profile of
location-based UPE may provide important information regarding the disease. We then
interpreted the differences and similarities between the two groups with respect to their
correlation structures.
Fig. 1 Schematic figure of CCD set-up as well as locations for UPE measurements on mouse front and hind
paws. Adapted from E. van Wijk et al. 2013
4
CR
IP
T
ACCEPTED MANUSCRIPT
AN
US
Fig. 2. Bio-photonic variance is revealed by location-based UPE-to-UPE correlation networks. The figure
illustrates the differences in correlations between CIA mice (a) and Ctrl mice (b). In CIA mice, the strong
correlations also indicate a strong similarity in UPE between the LFP (left front paw) and RFP (right front paw), as
well as between the LHP (left hind paw) and RHP (right hind paw). The numbers (1 through 5) indicate the specific
locations for the measurements (see Materials and Methods), (raw data are presented in supplemental table 1). Thus,
the differences between the front paws and hind paws are clearly visible in the CIA group. The networks were
established using the Spearman correlation analysis, and the lines represent Spearman correlation coefficients
(|r|) >0.7.
ED
M
The correlations were quantified using the parameters (i.e., |r| values and p-values)
obtained from the Spearman correlation analysis. In total, 71 and 26 strongly positive UPEto-UPE correlations were found in the CIA and Ctrl groups, respectively; no strongly
negative correlations were found. The difference in the number of strongly positive
correlations between the CIA and Ctrl groups can be seen visually in Fig. 2. In the CIA group,
UPE intensity was tightly correlated between the two front paws and between the two hind
paws (Fig. 2a). In contrast, we found no clear correlation patterns in the Ctrl group (Fig. 2b).
3.2 Differences in metabolite correlations between CIA mice and control mice
AC
CE
PT
Next, we acquired metabolic data from plasma samples using HPLC-MS/MS (raw data are
presented in supplemental table 2). The following three groups of metabolites were extracted
using three validated methods and detected using three specific instruments: amine
metabolites (including free amino acids and their biogenic metabolites), oxylipins, and
oxidative stress‒related metabolites. A total of 110 endogenous metabolites were detected in
the plasma samples, including 30 oxylipins, 45 amine metabolites, and 35 oxidative stress‒
related lipids. Univariate and multivariate analyses were then applied to the metabolite sets in
order to characterize the differences between CIA mice and Ctrl mice at the metabolomics
level. Previously, we reported the differences between CIA mice and Ctrl mice with respect
to oxylipins and amine metabolites [14] , [19]. Based on the oxidative stress platform, after
log transformation and auto-scaling of the data, we also found a number of key metabolites
that differed between the CIA the Ctrl groups (p<0.05, Student’s t-test). Table 1 summarizes
the key metabolites that differed significantly between the CIA and Ctrl groups.
Table 1. Summary of the key metabolites that differed significantly between the CIA and Ctrl groups
Oxylipins
Compound
9,10-DiHOME
Changes
↓
Amine metabolites
Compound
Changes
Methionine
↓
Oxidative stress
Compound
Changes
PGE3
↓
5
ACCEPTED MANUSCRIPT
↓
Homocysteine
↓
8,12-iso-iPF2a
↓
↑
Threonine
↓
cyclic-LPA C16:0
↓
14-HDoHE
12,13-DiHOME
↑
↓
Proline
Alanine
↓
↓
cyclic-LPA C18:2
↓
9,12,13-TriHOME
12-HEPE
9,10,13-TriHOME
↓
↑
↓
Valine
Cystathionine
Lysine
↓
↓
↓
9,10-EpOME
10-HDoHE
↓
↑
Glycylglycine
Serine
↓
↓
9-HODE*
8-HETE*
13-KODE*
↓
↑
↓
↓
↓
↓
12,13-EpOME*
↓
13,14-dihydro-PGF2a*
↑
Asparagine
Cysteine
Tryptophan
Methionine
sulfoxide
Homocitrulline
12-HETE*
↑
Isoleucine
CR
IP
T
9-KODE
13-HDoHE
↓
↓
↓
Gammaglutamylalanine
↓
AN
US
Histidine
↓
Glutamine
↓
Leucine
↓
Abbreviations: DiHOME, dihydroxyoctadeca(mono)enoic acid; EpOME, epoxyoctadecamonoenoic acid; HDoHE,
hydroxydocosahexaenoic acid; HEPE, hydroxyeicosapentaenoic acid; HETE, hydroxyeicosatetraenoic acid;
HODE, hydroxyoctadecadienoic acid; KODE, ketooctadecadienoic acid; PG, prostaglandin; TriHOME,
trihydroxyoctadecenoic acid.
↓: Decreased in CIA mice; ↑: Increased in CIA mice; *: Extra important oxylipins which contributed to the group
clustering are based on multivariate analysis (VIP>1).
AC
CE
PT
ED
M
Differences in metabolites generally do not occur independently, but often change
together with other, related metabolites, as metabolic reactions are often part of a dynamic
system and have many biological processes in common [35]. Metabolic network analysis is
an emerging approach used to diagnose disease , and it has the advantage of integrating
“omics” datasets in order to identify links and select useful information from among chaos
[34], [43]. We therefore performed a correlation network analysis in order to visualize pairwise metabolic correlations and to extract novel information regarding dynamic alternatives.
A merge between the metabolite-to-metabolite correlation networks measured in the plasma
of CIA and Ctrl mice is illustrated in fig. 3a and 3b, respectively. Next, the Spearman
correlation coefficient between metabolites (rm) was calculated, and only strong correlations
(either positive or negative) (i.e., with an |rm| value >0.7) were included in the resulting
network. We found a total of 394 positive correlations and 91 negative correlations in the
CIA group, and a total of 864 positive correlations and 117 negative correlations in the Ctrl
group (raw data of correlation results see supplemental table 3). In general, metabolites that
are in the same chemical class or in the same biochemical pathway tended to correlate with
each other; these so-called “chemical class-based” clusters and “pathway-based” clusters
were more pronounced in the Ctrl group, leading a highly connected region among oxylipins
and another region among amine metabolites. This network analysis revealed certain
structural or pathway similarities among those highly connected metabolites with respect to
significant positive correlations. Moreover, the associations between oxylipins and amine
metabolites were relatively weak in the Ctrl group, possible because oxylipins and amine
metabolites are generated via two separate metabolic pathways.
6
ACCEPTED MANUSCRIPT
(a) Metabolite-to metabolite correlations from CIA group
Oxylipins
Amino acids
Oxidative stress
Significantly increased
Significantly decreased
Oxylipins
(12-LOX)
CR
IP
T
Oxylipins
(ROS-related)
US
Amino acids
(b) Metabolite-to metabolite correlations from Ctrl group
Oxylipins
Amino acids
Oxidative stress
Oxylipins
Amino acids
AC
CE
PT
ED
M
AN
Significantly increased
Significantly decreased
Fig. 3. Metabolic correlation networks in the CIA and Ctrl groups. Depicted are the metabolite-to-metabolite
correlation networks for CIA (3a) and Ctrl (3b) mice. All of the metabolites detected in our analysis are included in
the networks models. Nodes with a positive correlation are indicated with solid red lines, and nodes with a negative
correlation are indicated by solid blue lines. Shaded ellipses with a light red or light blue background indicate
clusters of oxylipins or amine metabolites, respectively. Thickness of lines indicate gradient correlation strength: the
thicker the line is, the stronger the correlation is (visible correlation co-efficiency: |r| ranges from 0.7 to 1).
Interestingly, we found that some of the strong correlations in the Ctrl group—including
both “oxylipin-to-oxylipin” and “amine-to-amine” correlations—were weaker in the CIA
group. In contrast, the CIA group contained more negative oxylipin-to-amine correlations
(Fig. 3a) than the Ctrl group (Fig. 3b). For example, the HETEs and HDoHEs that were
7
ACCEPTED MANUSCRIPT
elevated in CIA mice were strongly correlated with the branched chain amino acids valine,
leucine, and isoleucine, as well as with cystathionine, alanine, glutamine, and asparagine. The
use of HETEs and HDoHEs as inflammatory/ROS-related biomarkers has been described
previously [14], and we also found that decreases in these amine metabolites may reflect
muscle wasting and/or energy expenditure (cachexia) in RA [19]. Therefore, our analysis of
metabolic correlation networks suggests that the increased inflammation and ROS levels
reflected by oxylipins may also be associated with the onset of muscle wasting and increased
energy expenditure in RA.
3.3 UPE is correlated with inflammatory signaling‒related metabolites in CIA mice
AC
CE
PT
ED
M
AN
US
CR
IP
T
As discussed in the Introduction, UPE arises as a result of metabolic reactions, particularly
oxidation-reduction (redox) reactions; therefore, we hypothesized that UPE emission patterns
may be correlated with metabolite patterns. To test this hypothesis, we created a correlation
network to visualize potential associations between UPE intensity and peak area ratios of
measured metabolites (see Materials and Methods). Therefore, we used UPE-to-metabolite
correlations (i.e., between a given UPE value, u, and a given metabolite, m) in the correlation
networks, and the Spearman correlation coefficient |r um| was calculated for each UPEmetabolite pair in both the CIA group and the Ctrl group.
The heat map in Fig. 4 depicts a general UPE-to-metabolite correlation profile used to
compare the differences measured between the CIA group and the Ctrl group (data see in
supplemental table 4). A cluster analysis reveals clear location-based clusters in the CIA mice.
The heat map also indicates a systemic change in the CIA group (i.e., the majority of positive
correlations, shown in red) compared with the Ctrl group (i.e., the majority of negative
correlations, shown in green). After removing relative weaker coefficient from the Spearman
correlation analysis (|rum|<0.7), networks were built to reflect the highly correlated entities
and to show the most important metabolites (fig.4b). After we removed the relatively weaker
correlations from the Spearman correlation analysis (i.e., |rum| values <0.7), we built a
network to reflect the strongly correlated entities and to illustrate the most relevant
metabolites (Fig. 4b). Circle-attributed networks were then used to identify the key
correlations and to compare the CIA group with the Ctrl group. A total of 27 strongly
positive correlations and 79 negative correlations were identified in the Ctrl group, and a total
of 146 positive and 9 negative correlations were identified in the CIA group.
8
PT
ED
M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
AC
CE
Fig. 4. Correlation-based analysis between UPE and metabolites measured in the plasma of CIA mice and
Ctrl mice. a) Heat map showing the entire UPE-metabolite correlation profile, as well as the differences between the
CIA and Ctrl mice. Colored blocks represent the value of the correlation coefficient, which were color-coded from 1
(strongly positive, light red) to -1 (strongly negative, light green). b) Visualized network model of the strong
correlations (defined as a |rum| value >0.7). Several important pathway-related networks reflect the inflammation,
ROS production, and muscle wasting associated with RA. Each dot indicates an individual parameter that includes a
given metabolite and UPE value: yellow dots reflect location-based UPE intensity, and black, gray, and white dots
represent oxylipins, biogenic amines, and oxidative stress‒related metabolites, respectively. Also shown (between
the Ctrl and CIA network models) are enlarged views of the key metabolites that differed significantly based on our
univariate and multivariate analyses. The up-triangles and down-triangles indicate the direction of the metabolic
change in the CIA mice (i.e., up-regulation or down-regulation, respectively). The red and blue lines indicate
positive and negative correlations, respectively, and the thickness of the lines indicate the strength of the correlation.
The correlation networks revealed that the majority of UPE-to-metabolite correlations in
the Ctrl group were negative, whereas the majority of UPE-to-metabolite correlations in the
CIA group were strongly positive. The major metabolites that were positively correlated with
UPE in the CIA group are the monohydroxyeicosatetraenoic acids (HETEs), prostaglandins
(PGs), thromboxane (TBX) synthase products, lysophosphatidic acids (LPAs), sphingolipid
signaling molecules, and some amine metabolites (Fig. 4b). UPE intensity measured at
9
ACCEPTED MANUSCRIPT
Alpha-aminobutyric acid
Alanine
CE
Norepinephrine
Phospholipids
PUFAs
UPE
AA
COX II
PT
ED
M
AN
US
CR
IP
T
various locations was correlated with various metabolites in the CIA group. For example,
UPE intensity in the front paws was more strongly correlated with some LPAs, whereas UPE
intensity in the hind paws was more strongly correlated with PGs (13,14-dihydro-15-ketoPGF2a, PGE2, PGD2, and 6-keto-PGF2a), TBX synthase products (TBX2 and 12-HHTrE),
HETEs (8-HETE, 15-HETE, 11-HETE, and 12-HETE), and sphingolipids; see the CIA
correlation networks in Fig. 4b.
Next, the pathways related to these metabolites based on our previous study [14] and the
Kyoto Encyclopedia of Genes and Genomes were organized (Fig. 5). LPAs act on G protein‒
coupled signaling and cellular signaling responses and function as inflammatory mediators
[44], [45]. PGs and TBXs, which are synthesized from arachidonic acid via COX-II pathways,
have well-established pro-inflammatory functions [46], [47]. The 12/15-LOX products (12HETE, 15-HETE, and 8-HETE) promote the production of cytokines and activate the NF-κB
pathway to inhibit cellular apoptosis [48], [49]. In addition, 8-HETE, 12-HETE, and 11HETE can also be peroxided non-enzymatically by ROS to inhibit apoptosis [50]–[54];
therefore, these three HETEs may be important inflammatory mediators [55], [56]. The
sphingomyelin-derived sphingolipids sphingosine and sphingosine-1-phosphate (S1P) are
signaling molecules in immune cells that mediate neutrophil activation and apoptosis, and are
therefore also considered to be inflammatory mediators [57]–[62]. Based on the correlation
networks, it can be seen that these inflammatory mediators participated in the systemic
perturbations (measured using both metabolomics and UPE) in the CIA mice, even though
some of these mediators were not altered significantly in our univariate analysis. We also
conclude that UPE intensity is correlated with systemic inflammatory mediators, ROS
mediators, and cellular signaling processes; therefore, measuring UPE intensity may provide
a means to diagnose inflammatory disease. In addition, UPE may also be used to monitor
lipid peroxidation which relate to inflammation and ROS level in both healthy and diseased
individuals (Fig. 6). Thus, a specific phenotype of a disease can be complemented by
measuring both “omics” profiles and UPE patterns, thereby providing a more detailed
understanding of the disease and its underlying processes.
LOX, ROS
PGs, TXs
HETEs
PGD2
11-HETE
PGE2
Glucose
8-HETE
13,14-dihydro-15-keto-PGF2a
Pyruvate
TXB2
15-HETE
(Tyrosine metabolism)
Beta-alanine
Aspartic acid
Inflammatory response
Response to Stress
Pyruvic acid
Citrulline
AC
Spermidine
Alanine, aspartate and
glutamate metabolism
12-HETE
Ornithine
Glutathione
Serine
Glutamic acid
Tryptophan
Arginine
Sarcosine
TCA cycle
Serotonin
Glutathione
metabolism
Serine
metabolism
Phospholipids
(PCs)
Sphingophospholipid
metabolism
Lysophosphatidylcholine
(LPCs)
LPAs
Sphingosine
Sphingosine-1-P
Sphingolipid metabolism
(Cellular signaling)
Fig. 5. Putative biochemical pathways with metabolites that can be correlated with UPE. UPE intensity can be
linked to inflammatory responses and ROS-related stress in RA, which are reflected by COX-II and 12/15-LOX
oxylipins derived from arachidonic acid (AA). During cell signaling, the production of LPAs and sphingosine also
associates with the increased UPE intensity. Another pathway that may be linked with UPE intensity is the TCA
cycle.
10
ACCEPTED MANUSCRIPT
Rheumatoid arthritis
Cytokines
(TNF-a, IL-1b, IL-6)
Net Protein catabolism
nt)
(Ins
uli
sista
n re
Biophotonic
disturbance
Dysregulation in
Immune response
Insulin pathway
(MAPK
Metabolic
dysregulations
Cell signalling
UPE intensity
mTOR)
Protein sythesis
Apoptosis
resistant
Protein catabolism
CR
IP
T
NF-kB activation
LPAs
Sphingosine
Anti-inflammatory oxylipins
Inflammatory response
Skeletal muscle Mass
Oxylipins Pro-inflammatory oxylipins
Amino acids
Energy
ROS
Tissue damage
Joint pain
US
Rheumatoid Cachexia
Response to stress
AN
Physical disability, muscle weakness, increased risk of inflammation and infection
M
Fig. 6. Systemic and dynamic changes in RA. The production of cytokines dynamically interrupts living systems at
both the biochemical level (i.e., the proteomics and metabolomics levels) and the bio-photon level. In addition, the
biochemical changes are in correlation to the UPE changes. Elements marked in red/green are those
increased/decreased in our CIA mice model.
AC
CE
PT
ED
In the CIA mice, a strongly negative correlation between cystathionine and UPE was
measured, whereas several amine metabolites—including serotonin, tryptophan, and aspartic
acid—were positively correlated with UPE. Cystathionine is a scavenger of free radicals [63];
therefore, given its significant decrease in CIA mice compared to Ctrl mice, the negative
correlation between cystathionine and UPE intensity indicates that the increase in UPE
intensity may be due to a decrease in antioxidants in RA. Both tryptophan metabolism and
the serotonergic system have been well described as key pathways that can influence
signaling in the central nervous system [64]. Thus, UPE may also be correlated with
metabolic systems that are associated with neurotransmission. In addition, based upon
pathways that regulate amine metabolites listed in the Kyoto Encyclopedia of Genes and
Genomes, all of the other amine metabolites that were positively correlated with UPE are
associated either directly or indirectly with the TCA cycle (see Fig. 5). The correlations
identified between UPE intensity and these metabolites may suggest that during disease,
some of the electrons that would otherwise participate in chemical reactions to produce
energy (for example, with amine metabolites in the TCA cycle) actually escape and set free
the energy which they carry, as photons, whereby the electrons change from high to low
energy level states. Simultaneously, free radicals and/or ROS are produced, driving lipid
peroxidation to produce inflammatory HETEs and PGs. While such a speculation need more
rigorous validation.
The reduction in amine metabolites in the plasma of CIA mice compared to Ctrl mice
may be linked to the contribution of muscle wasting in arthritis [19]. Considering that we
found strong correlations between amine metabolites and UPE intensity, and given that
muscle wasting is a common feature in many disease processes, including some cancers [65],
HIV/AIDs [66], type 2 diabetes [67], renal failure, uremia[68], and heart failure [69] , UPE
11
ACCEPTED MANUSCRIPT
CR
IP
T
may also have potential perspective for the use of monitoring energy wasting and muscle
wasting in other diseases. In this respect, future studies should examine the relationship
between muscle wasting and UPE.
Interestingly, HETEs, PGs, sphingosine, and S1P—which were strongly correlated with
UPE intensity in our study—are also considered to be important inflammatory biomarkers in
a variety of diseases, including RA [70], cardiovascular disease and/or atherosclerosis‒
related inflammation [59], [61], [71], [72], congestive heart failure[60], cancers and other
tumors [54], [73], some prostate diseases [55] , and nonalcoholic steatohepatitis [56].
Therefore, our finding that UPE is correlated with these inflammatory mediators may shed
light on the biological mechanisms that underlie these diseases from a systems biology
perspective.
4. Conclusions
PT
ED
M
AN
US
Given its complex pathophysiology, RA has been studied using a variety of technologies and
approaches. Indeed, integrating various data sets can provide important information regarding
the disease process and possible treatment strategies. Generating correlation networks can
provide valuable information, and these networks have been used recently within a wide
range of “omics” studies, including proteomics, genomics, and metabolomics, thereby
helping distinguish specific diseases and/or phenotypes [34], [35], [74]. Here, we performed
the first study that integrates UPE with metabolomics in both diseased mice (i.e., mice with
collagen-induced arthritis) and healthy control mice; this novel, powerful approach yielded
meaningful information regarding RA. Moreover, we found specific correlations between
metabolomics and UPE. Lastly, our correlation network analysis shows a systematic way to
illustrate the complexity of RA , including dysregulation of both UPE and metabolomics.
Using our correlation networks, we also found that oxylipins were negatively correlated
with certain amine metabolites in the CIA group. This may indicate a systematic perturbation
under inflammation and ROS response in RA-induced situation. However, further study is
needed in order to elucidate whether the inflammation and ROS are the consequence of
muscle wasting, or vice versa. We also found that UPE was correlated with certain
inflammatory mediators, and we expanded the biological interpretation of RA using
correlation networks.
In conclusion, our correlation network analysis provides valuable information regarding
the disease process from a system-wide perspective. Understanding the underlying
biochemical phenomena that give rise to UPE is of great importance to learn about potential
applications of UPE in early disease characterization.
CE
5. Acknowledgments
AC
Min He was supported by the Chinese Scholarship Council (Scholarship File Number
20108220166) and 973 Program (No. 2014CB543100). Additional support was provided by
the Samueli Institute in Alexandria, VA. The authors are grateful to Prof. Masaki Kobayashi
at the Tohoku Institute of Technology in Sendai, Japan for providing the use of laboratory
facilities and for collecting plasma samples. We are also grateful to Johannes C. Schoeman
for support preparing the oxidative stress samples and for help with data processing.
12
ACCEPTED MANUSCRIPT
6. References and links
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
AC
[21]
CR
IP
T
[7]
US
[6]
AN
[5]
M
[4]
ED
[3]
PT
[2]
Y. Alamanos and A. Drosos, “Epidemiology of adult rheumatoid arthritis,” Autoimmun. Rev., vol. 4, no. 3,
pp. 130–136, 2005.
S. E. Gabriel, “The epidemiology of rheumatoid arthritis.,” Rheum. Dis. Clin. North Am., vol. 27, no. 2, pp.
269–281, 2001.
G. S. Firestein, “Evolving concepts of rheumatoid arthritis.,” Nature, vol. 423, no. 6937, pp. 356–61, May
2003.
E. H. Choy and G. S. Panayi, “Cytokine pathways and joint inflammation in rheumatoid arthritis.,” N. Engl.
J. Med., vol. 344, no. 12, pp. 907–916, Mar. 2001.
G. Ferraccioli, L. Bracci-Laudiero, S. Alivernini, E. Gremese, B. Tolusso, and F. De Benedetti,
“Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute
to chronic inflammation and relevance for human rheumatoid arthritis.,” Mol. Med., vol. 16, no. 11–12, pp.
552–7, 2010.
S. S. Makarov, “NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and
tissue destruction.,” Arthritis Res., vol. 3, no. 4, pp. 200–206, 2001.
R. Holmdahl, R. Bockermann, J. Bäcklund, and H. Yamada, “The molecular pathogenesis of collageninduced arthritis in mice--a model for rheumatoid arthritis.,” Ageing Res. Rev., vol. 1, no. 1, pp. 135–47,
Feb. 2002.
A.-K. B. Lindqvist, R. Bockermann, Å. C. M. Johansson, K. S. Nandakumar, M. Johannesson, and R.
Holmdahl, “Mouse models for rheumatoid arthritis,” Trends Genet., vol. 18, no. 6, pp. S7–S13, Jun. 2002.
K. S. Nandakumar and R. Holmdahl, “Efficient promotion of collagen antibody induced arthritis (CAIA)
using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced
arthritis and rheumatoid arthritis.,” J. Immunol. Methods, vol. 304, no. 1–2, pp. 126–36, Sep. 2005.
D. D. Brand, K. a Latham, and E. F. Rosloniec, “Collagen-induced arthritis.,” Nat. Protoc., vol. 2, no. 5, pp.
1269–1275, 2007.
J. Eguchi, T. Koshino, T. Takagi, T. Hayashi, and T. Saito, “NF-kappa B and I-kappa B overexpression in
articular chondrocytes with progression of type II collagen-induced arthritis in DBA/1 mouse knees.,” Clin.
Exp. Rheumatol., vol. 20, no. 5, pp. 647–52, 2002.
R. Ramautar, R. Berger, J. van der Greef, and T. Hankemeier, “Human metabolomics: Strategies to
understand biology,” Curr. Opin. Chem. Biol., vol. 17, no. 5, pp. 841–846, 2013.
H. Van Wietmarschen and J. Van Der Greef, “Metabolite Space of Rheumatoid Arthritis,” Br. J. Med. Med.
Res., vol. 2, no. 3, pp. 469–483, 2012.
M. He, E. Van Wijk, R. Berger, M. Wang, K. Strassburg, C. Schoeman, R. J. Vreeken, H. Van
Wietmarschen, A. C. Harms, T. Hankemeier, and J. Van Der Greef, “Collagen Induced Arthritis in DBA /
1J Mice Associates with Oxylipin Changes in Plasma,” Mediators Inflamm., vol. 2015, pp. 1–11, 2015.
J. Walsmith and R. Roubenoff, “Cachexia in rheumatoid arthritis,” Int. J. Cardiol., vol. 85, no. 1, pp. 89–99,
2002.
R. Roubenoff, “Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and
osteoarthritis.,” Ann. N. Y. Acad. Sci., vol. 904, pp. 553–7, May 2000.
O. M. da Rocha, A. D. A. P. Batista, N. Maestá, R. C. Burini, and I. M. M. Laurindo, “Sarcopenia in
rheumatoid cachexia: Definition, mechanisms, clinical consequences and potential therapies,” Rev. Bras.
Reumatol., vol. 49, no. 3, pp. 294–301, 2009.
G. D. Summers, C. M. Deighton, M. J. Rennie, and A. H. Booth, “Rheumatoid cachexia: a clinical
perspective,” Rheumatology, vol. 47, no. 8, pp. 1124–1131, 2008.
M. He, A. C. Harms, E. van Wijk, M. Wang, R. Berger, S. Koval, T. Hankemeier, and J. van der Greef,
“The role of amino acids in rheumatoid arthritis studied by metabolomics,” Manuscript under review,
Journal of International Journal of Rheumatic Diseases.
E. van Wijk, M. Kobayashi, R. van Wijk, and J. van der Greef, “Imaging of ultra-weak photon emission in a
rheumatoid arthritis mouse model,” PloS one, vol. 8, no. 12. p. e84579, Jan-2013.
M. Cifra and P. Pospíšil, “Ultra-weak photon emission from biological samples: Definition, mechanisms,
properties, detection and applications,” J. Photochem. Photobiol. B Biol., vol. 139, pp. 2–10, Oct. 2014.
M. Kobayashi, M. Takeda, T. Sato, Y. Yamazaki, K. Kaneko, K. Ito, H. Kato, and H. Inaba, “In vivo
imaging of spontaneous ultraweak photon emission from a rat’s brain correlated with cerebral energy
metabolism and oxidative stress.,” Neurosci. Res., vol. 34, no. 2, pp. 103–13, Jul. 1999.
R. Van Wijk, E. Van Wijk, F. Wiegant, and J. Ives, “Free radicals and low-level photon emission in human
pathogenesis: state of the art.,” Indian J. Exp. Biol., vol. 46, no. 5, pp. 273–309, May 2008.
R. Van Wijk, E. Van Wijk, H. van Wietmarschen, and J. Van der Greef, “Towards whole-body ultra-weak
photon counting and imaging with a focus on human beings: A review,” J. Photochem. Photobiol. B Biol.,
vol. 139, pp. 39–46, Oct. 2014.
A. Rastogi and P. Pospísil, “Spontaneous ultraweak photon emission imaging of oxidative metabolic
processes in human skin: effect of molecular oxygen and antioxidant defense system.,” J. Biomed. Opt., vol.
16, no. 9, p. 96005, 2011.
P. Pospíšil, A. Prasad, and M. Rác, “Role of reactive oxygen species in ultra-weak photon emission in
CE
[1]
[22]
[23]
[24]
[25]
[26]
13
ACCEPTED MANUSCRIPT
[34]
[35]
[36]
[37]
[38]
[39]
[40]
[41]
[42]
[43]
AC
[44]
CR
IP
T
[33]
US
[32]
AN
[31]
M
[30]
ED
[29]
PT
[28]
biological systems,” J. Photochem. Photobiol. B Biol., vol. 139, pp. 11–23, Oct. 2014.
A. Prasad and P. Pospíšil, “Linoleic acid-induced ultra-weak photon emission from Chlamydomonas
reinhardtii as a tool for monitoring of lipid peroxidation in the cell membranes.,” PloS one, vol. 6, no. 7. p.
e22345, Jan-2011.
J. A. Ives, E. van Wijk, N. Bat, C. Crawford, A. Walter, W. B. Jonas, R. van Wijk, and J. van der Greef,
“Ultraweak Photon Emission as a Non-Invasive Health Assessment: A Systematic Review,” PLoS One, vol.
9, no. 2, p. e87401, Feb. 2014.
M. He, M. Sun, E. van Wijk, H. van Wietmarschen, R. van Wijk, Z. Wang, M. Wang, T. Hankemeier, and J.
van der Greef, “A Chinese literature overview on ultra-weak photon emission as promising technology for
studying system-based diagnostics,” Complement. Ther. Med., vol. 25, pp. 20–26, 2016.
A. Rastogi and P. Pospísil, “Spontaneous ultraweak photon emission imaging of oxidative metabolic
processes in human skin: effect of molecular oxygen and antioxidant defense system.,” J. Biomed. Opt., vol.
16, no. 9, p. 96005, Sep. 2011.
C. de Mello Gallep, “Ultraweak, spontaneous photon emission in seedlings: toxicological and
chronobiological applications,” Luminescence, vol. 29, no. 8, pp. 963–968, Dec. 2014.
S. E. Calvano, W. Xiao, D. R. Richards, R. M. Felciano, H. V Baker, R. J. Cho, R. O. Chen, B. H.
Brownstein, J. P. Cobb, S. K. Tschoeke, C. Miller-Graziano, L. L. Moldawer, M. N. Mindrinos, R. W.
Davis, R. G. Tompkins, and S. F. Lowry, “A network-based analysis of systemic inflammation in humans.,”
Nature, vol. 437, no. 7061, pp. 1032–7, Oct. 2005.
A.-L. Barabasi, N. Gulbahce, and J. Loscalzo, “Network medicine: a network-based approach to human
disease.,” Nat. Rev. Genet., vol. 12, no. 1, pp. 56–68, 2011.
Y. Noguchi and N. Shikata, “Characterization of dietary protein-dependent amino acid metabolism by
linking free amino acids with transcriptional profiles through analysis of correlation,” Physiol. …, vol. 34,
no. 3, pp. 315–326, 2008.
K. Morgenthal, W. Weckwerth, and R. Steuer, “Metabolomic networks in plants: Transitions from pattern
recognition to biological interpretation,” BioSystems, vol. 83, no. 2–3 SPEC. ISS., pp. 108–117, 2006.
J. van der Greef, S. Martin, P. Juhasz, A. Adourian, T. Plasterer, E. R. Verheij, and R. N. McBurney, “The
art and practice of systems biology in medicine: mapping patterns of relationships.,” J. Proteome Res., vol.
6, no. 4, pp. 1540–59, Apr. 2007.
C. a Hidalgo, N. Blumm, A.-L. Barabási, and N. a Christakis, “A dynamic network approach for the study
of human phenotypes.,” PLoS Comput. Biol., vol. 5, no. 4, p. e1000353, Apr. 2009.
S. Yoshino, E. Sasatomi, and M. Ohsawa, “Bacterial lipopolysaccharide acts as an adjuvant to induce
autoimmune arthritis in mice.,” Immunology, vol. 99, no. 4, pp. 607–14, Apr. 2000.
K. Strassburg, A. M. L. Huijbrechts, K. a Kortekaas, J. H. Lindeman, T. L. Pedersen, A. Dane, R. Berger, A.
Brenkman, T. Hankemeier, J. van Duynhoven, E. Kalkhoven, J. W. Newman, and R. J. Vreeken,
“Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac
surgery.,” Anal. Bioanal. Chem., vol. 404, no. 5, pp. 1413–26, Sep. 2012.
M. J. Noga, A. Dane, S. Shi, A. Attali, H. van Aken, E. Suidgeest, T. Tuinstra, B. Muilwijk, L. Coulier, T.
Luider, T. H. Reijmers, R. J. Vreeken, and T. Hankemeier, “Metabolomics of cerebrospinal fluid reveals
changes in the central nervous system metabolism in a rat model of multiple sclerosis.,” Metabolomics, vol.
8, no. 2, pp. 253–263, Apr. 2012.
P. Shannon, A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, N. Amin, B. Schwikowski, and T.
Ideker, “Cytoscape: a software environment for integrated models of biomolecular interaction networks.,”
Genome Res., vol. 13, no. 11, pp. 2498–504, Nov. 2003.
J. Gao, V. G. Tarcea, A. Karnovsky, B. R. Mirel, T. E. Weymouth, C. W. Beecher, J. D. Cavalcoli, B. D.
Athey, G. S. Omenn, C. F. Burant, and H. V. Jagadish, “Metscape: A Cytoscape plug-in for visualizing and
interpreting metabolomic data in the context of human metabolic networks,” Bioinformatics, vol. 26, no. 7,
pp. 971–973, 2010.
T. Kimura, Y. Noguchi, N. Shikata, and M. Takahashi, “Plasma amino acid analysis for diagnosis and
amino acid-based metabolic networks.,” Curr. Opin. Clin. Nutr. Metab. Care, vol. 12, no. 1, pp. 49–53, Jan.
2009.
W. H. Moolenaar, O. Kranenburg, F. R. Postma, and G. C. M. Zondag, “Lysophosphatidic acid: G-protein
signalling and cellular responses,” Curr. Opin. Cell Biol., vol. 9, no. 2, pp. 168–173, 1997.
C. Zhao, M. J. Fernandes, G. D. Prestwich, J. Di Battista, T. Clair, P. E. Poubelle, and S. G. Bourgoin,
“Regulation of Lysophosphatidic Acid Receptor Expression and Function in Human Synoviocytes :
Implications for Rheumatoid Arthritis ?,” Mol. Pharmacol., vol. 73, no. 2, pp. 587–600, 2008.
K. Takayama, K. Yuhki, K. Ono, T. Fujino, A. Hara, T. Yamada, S. Kuriyama, H. Karibe, Y. Okada, O.
Takahata, T. Taniguchi, T. Iijima, H. Iwasaki, S. Narumiya, and F. Ushikubi, “Thromboxane A2 and
prostaglandin F2alpha mediate inflammatory tachycardia,” Nat. Med., vol. 11, no. 5, pp. 562–566, 2005.
N. Sugino, A. Karube-Harada, T. Taketani, A. Sakata, and Y. Nakamura, “Withdrawal of ovarian steroids
stimulates prostaglandin F2alpha production through nuclear factor-kappaB activation via oxygen radicals
in human endometrial stromal cells: potential relevance to menstruation.,” J. Reprod. Dev., vol. 50, no. 2,
pp. 215–225, 2004.
S. K. Chakrabarti, B. K. Cole, Y. Wen, S. R. Keller, and L. Nadler, “12/15-Lipoxygenase Products Induce
Inflammation and Impair Insulin Signaling in 3T3-L1 Adipocytes,” Obesity, vol. 17, no. 9, pp. 1657–1663,
CE
[27]
[45]
[46]
[47]
[48]
14
ACCEPTED MANUSCRIPT
[56]
[57]
[58]
[59]
[60]
[61]
[62]
[63]
[64]
[65]
AC
[66]
CR
IP
T
[55]
US
[54]
AN
[53]
M
[52]
ED
[51]
PT
[50]
2009.
M. Kandouz, D. Nie, G. P. Pidgeon, S. Krishnamoorthy, K. R. Maddipati, and K. V. Honn, “Platelet-type
12-lipoxygenase activates NF-kB in prostate cancer cells,” Prostaglandins Other Lipid Mediat., vol. 71, no.
3–4, pp. 189–204, 2003.
S. J. Muga, P. Thuillier, a Pavone, J. E. Rundhaug, W. E. Boeglin, M. Jisaka, a R. Brash, and S. M.
Fischer, “8S-lipoxygenase products activate peroxisome proliferator-activated receptor alpha and induce
differentiation in murine keratinocytes.,” Cell Growth Differ., vol. 11, no. 8, pp. 447–54, Aug. 2000.
R. A. Daynes and D. C. Jones, “Emerging roles of PPARs in inflammation and immunity.,” Nat. Rev.
Immunol., vol. 2, no. 10, pp. 748–59, Oct. 2002.
H. Kühn and V. B. O'Donnell, “Inflammation and immune regulation by 12/15-lipoxygenases,”
Progress in Lipid Research, vol. 45, no. 4. pp. 334–356, 2006.
M. H. Shishehbor, R. Zhang, H. Medina, M.-L. Brennan, D. M. Brennan, S. G. Ellis, E. J. Topol, and S. L.
Hazen, “Systemic elevations of free radical oxidation products of arachidonic acid are associated with
angiographic evidence of coronary artery disease.,” Free Radic. Biol. Med., vol. 41, no. 11, pp. 1678–83,
Dec. 2006.
G. P. Pidgeon, J. Lysaght, S. Krishnamoorthy, J. V Reynolds, K. O’Byrne, D. Nie, and K. V Honn,
“Lipoxygenase metabolism: roles in tumor progression and survival.,” Cancer Metastasis Rev., vol. 26, no.
3–4, pp. 503–24, Dec. 2007.
K. Nithipatikom, M. A. Isbell, W. A. See, and W. B. Campbell, “Elevated 12- and 20hydroxyeicosatetraenoic acid in urine of patients with prostatic diseases,” Cancer Lett., vol. 233, no. 2, pp.
219–225, 2006.
P. Puri, M. M. Wiest, O. Cheung, F. Mirshahi, C. Sargeant, H.-K. Min, M. J. Contos, R. K. Sterling, M.
Fuchs, H. Zhou, S. M. Watkins, and A. J. Sanyal, “The plasma lipidomic signature of nonalcoholic
steatohepatitis,” Hepatology, vol. 50, no. 6, pp. 1827–38, Dec. 2009.
M. Maceyka, S. G. Payne, S. Milstien, and S. Spiegel, “Sphingosine kinase, sphingosine-1-phosphate, and
apoptosis,” Biochim. Biophys. Acta - Mol. Cell Biol. Lipids, vol. 1585, no. 2–3, pp. 193–201, Dec. 2002.
Q. Liu, H. Rehman, Y. Shi, Y. Krishnasamy, J. J. Lemasters, C. D. Smith, and Z. Zhong, “Inhibition of
sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats.,”
PLoS One, vol. 7, no. 7, p. e41834, 2012.
F. Roviezzo, V. Brancaleone, L. De Gruttola, V. Vellecco, M. Bucci, B. D’Agostino, D. Cooper, R.
Sorrentino, M. Perretti, and G. Cirino, “Sphingosine-1-phosphate modulates vascular permeability and cell
recruitment in acute inflammation in vivo.,” J. Pharmacol. Exp. Ther., vol. 337, no. 3, pp. 830–7, Jun. 2011.
L. Dalla Libera, R. Sabbadini, C. Renken, B. Ravara, M. Sandri, R. Betto, A. Angelini, and G. Vescovo,
“Apoptosis in the Skeletal Muscle of Rats with Heart Failure is Associated with Increased Serum Levels of
TNF-α and Sphingosine,” J. Mol. Cell. Cardiol., vol. 33, no. 10, pp. 1871–1878, 2001.
S. Mahajan-Thakur, A. Böhm, G. Jedlitschky, K. Schrör, and B. H. Rauch, “Sphingosine-1-Phosphate and
Its Receptors: A Mutual Link between Blood Coagulation and Inflammation,” Mediators Inflamm., vol.
2015, pp. 1–11, 2015.
E. J. Goetzl, Y. Kong, and B. Mei, “Lysophosphatidic acid and sphingosine 1-phosphate protection of T
cells from apoptosis in association with suppression of Bax.,” J. Immunol., vol. 162, no. 4, pp. 2049–56,
Feb. 1999.
K. Wada, Y. Kamisaki, K. Nakamoto, and T. Itoh, “Effect of cystathionine as a scavenger of superoxide
generated from human leukocytes or derived from xanthine oxidase in vitro,” Eur. J. Pharmacol., vol. 296,
no. 3, pp. 335–340, 1996.
J. P. Ruddick, A. K. Evans, D. J. Nutt, S. L. Lightman, G. A. Rook, and C. A. Lowry, “Tryptophan
metabolism in the central nervous system: medical implications,” Expert Rev Mol Med, vol. 8, no. 20, pp.
1–27, 2006.
T. M. O’Connell, F. Ardeshirpour, S. A. Asher, J. H. Winnike, X. Yin, J. George, D. C. Guttridge, W. He,
A. Wysong, M. S. Willis, and M. E. Couch, “Metabolomic analysis of cancer cachexia reveals distinct lipid
and glucose alterations,” Metabolomics, vol. 4, no. 3, pp. 216–225, 2008.
C. Grunfeld and K. R. Feingold, “Metabolic disturbances and wasting in the acquired immunodeficiency
syndrome,” N. Engl. J. Med., vol. 330, pp. 1041–1046, 1994.
S. Park, B. Goodpaster, J. Lee, L. Kuller, R. Boudreau, N. De Rekeneire, T. Harris, S. Kritchevsky, F.
Tylavsky, M. Nevitt, Y. Cho, and A. Newman, “Excessive loss of skeletal muscle mass in older adults with
type 2 diabetes,” Diabetes Care, vol. 32, no. 11, pp. 1993–1997, 2009.
R. C. May, R. A. Kelly, and W. E. Mitch, “Mechanisms for defects in muscle protein metabolism in rats
with chronic uremia. Influence of metabolic acidosis.,” J. Clin. Invest., vol. 79, no. 4, pp. 1099–1103, 1987.
S. D. Anker and A. J. S. Coats, “Cardiac cachexia: A syndrome with impaired survival and immune and
neuroendocrine activation,” Chest, vol. 115, no. 3, pp. 836–847, 1999.
S. Homer-Vanniasinkam and M. J. Gough, “Role of lipid mediators in the pathogenesis of skeletal muscle
infarction and oedema during reperfusion after ischaemia,” Br. J. Surg., vol. 81, no. 10, pp. 1500–1503,
1994.
U. N. Das, “Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free
radicals: Relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular
diseases,” Prostaglandins, Leukot. Essent. Fat. Acids, vol. 44, no. 4, pp. 201–210, Dec. 1991.
CE
[49]
[67]
[68]
[69]
[70]
[71]
15
ACCEPTED MANUSCRIPT
[72]
[73]
AC
CE
PT
ED
M
AN
US
CR
IP
T
[74]
B. H. Maskrey, I. L. Megson, P. D. Whitfield, and A. G. Rossi, “Mechanisms of resolution of inflammation:
A focus on cardiovascular disease,” Arterioscler. Thromb. Vasc. Biol., vol. 31, no. 5, pp. 1001–1006, 2011.
B. Porro, P. Songia, I. Squellerio, E. Tremoli, and V. Cavalca, “Analysis, physiological and clinical
significance of 12-HETE: A neglected platelet-derived 12-lipoxygenase product,” J. Chromatogr. B, vol.
964, pp. 26–40, Aug. 2014.
A. D. Southam, J. M. Easton, G. D. Stentiford, C. Ludwig, T. N. Arvanitis, and M. R. Viant, “Metabolic
Changes in Flatfish Hepatic Tumours Revealed by NMR-Based Metabolomics and Metabolic Correlation
Networks,” J. Proteome Res, vol. 7, no. 12, pp. 5277–5285, 2008.
16
ACCEPTED MANUSCRIPT
Highlights
CR
IP
T
US
AN
M
ED
PT
CE
Correlation networks visualized differences of correlations in CIA mice versus
Control samples.
UPE was correlated with specific classes of metabolites.
By linking UPE to metabolomics, potential applications of UPE for disease
characterization could be identified.
AC
17